ENZYMATISCHE TUMORTHERAPIE
European patent · EP2147122 · In force
Register entry
- Publication number
- EP2147122
- Application number
- EP08754910
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Apr 18, 2008
- Published
- Jan 27, 2010
- Granted
- Jul 16, 2014
- Protection ends at the latest
- Apr 17, 2028
- Next annual fee due
- Apr 30, 2027
- IPC classes
- C12Q 1/68 (2006.01)A61K 38/50 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 913039 P 20.04.2007
- PCT application
- PCT/US2008/060733 18.04.2008
- PCT publication
- WO2008/131163 30.10.2008
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- May 1, 2026
Change
Published in Swissreg on 01.05.2026
- May 1, 2025
Change
Published in Swissreg on 01.05.2025
- May 1, 2024
Change
Published in Swissreg on 01.05.2024
- May 1, 2023
Change
Published in Swissreg on 01.05.2023
- May 18, 2022
Address changed
- Representative
- RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich → RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich
Published in Swissreg on 18.05.2022
- Mar 6, 2021
Transferred
- Owner
- Leadiant Biosciences Limited, 21 Holborn Viaduct, London EC1A 2DY, United Kingdom → Unikeris Limited, 333 Styal Road, Manchester M22 5LG, United Kingdom
Published in Swissreg on 06.03.2021
- Sep 26, 2017
Address changed
- Representative
- Rentsch Partner AG, Fraumünsterstrasse 9, Postfach 2441, 8022 Zürich → RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich
Published in Swissreg on 26.09.2017
- Mar 22, 2017
Address changed
- Owner
- Sigma-Tau Rare Disease Ltd, 21 Holborn Viaduct, London EC1A 2DY, United Kingdom → Leadiant Biosciences Limited, 21 Holborn Viaduct, London EC1A 2DY, United Kingdom
Published in Swissreg on 22.03.2017
4 earlier entries
- Nov 19, 2015
Transferred
- Owner
- Sigma-Tau Pharma Ltd., 21 Holborn Viaduct, EC1A 2DY London, United Kingdom → Sigma-Tau Rare Disease Ltd, 21 Holborn Viaduct, London EC1A 2DY, United Kingdom
Published in Swissreg on 19.11.2015
- Oct 18, 2014
Agent entered
- Representative
- Rentsch Partner AG, Fraumünsterstrasse 9, Postfach 2441, 8022 Zürich
Published in Swissreg on 18.10.2014
- Oct 18, 2014
Merged
- Owner
- Sigma-Tau Rare Diseases S.A., Rua dos Ferreiros no. 260, 9000-082 Funchal, Portugal → Sigma-Tau Pharma Ltd., 21 Holborn Viaduct, EC1A 2DY London, United Kingdom
Published in Swissreg on 18.10.2014
- Jul 16, 2014
Granted
Published in Swissreg on 16.07.2014
Parties
Inventor
Piscataway, NJ 08854, US
Edison, NJ 08820, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.